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Volume-reserving Surgery after Photodynamic Therapy for Biliary Papillomatosis: A Case 
Report
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Biliary papillomatosis is rare, and its pathogenic mechanisms are not yet clear. Because of its high risk for malignancy trans-
formation, surgical resection is regarded as a standard treatment. Photodynamic therapy (PDT) has been used by the intravenous 
administration of hematoporphyrin derivative followed by laser exposure. A photochemical process causes disturbance of the 
microvascular structure and degradation of membrane. Cholangitis is a major complication after PDT. A healthy 56-year-old 
man was diagnosed with biliary papillomatosis involving the common hepatic duct, both proximal intrahepatic bile ducts (IHD), 
and the right posterior IHD. After biliary decompression by endoscopic nasobiliary drainage, PDT was performed to avoid extensive 
liver resection and recurrence using endoscopic retrograde cholangiographic guidance. After portal vein embolization, the patient 
underwent extended right hemihepatectomy. Following administration of chemoradiation therapy with tegafur-uracil and 45 
Gy due to local recurrence at postoperative 13 months, there was no local recurrence or distant metastases. This is the 
first case report on PDT for biliary papillomatosis in Korea. Preoperative PDT is beneficial for reducing the lesion in diffuse 
or multifocal biliary papillomatosis and may lead to curative and volume reserving surgery. Thus, PDT could improve the quality 
of life and prolong life expectation for biliary papillomatosis patients. (Korean J Gastroenterol 2015;66:55-58)
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INTRODUCTION
Biliary papillomatosis, also known as benign papillary ad-
enoma, is a rare disease characterized by multiple intra-
ductal papillary tumors in the intrahepatic duct or extra-
hepatic duct with proliferated columnar epithelial cells.1 
However, it should be regarded as premalignancy disease 
with adenoma-carcinoma sequence.1 Pathogenic mecha-
nisms are not yet clear, although biliary papillomatosis is 
known to be associated with recurrent pyogenic cholangitis 
and chronic biliary ductal inflammation.2 Infection, clonorch-
iasis or pancreatic juice reflux causes extensive proliferation 
of biliary epithelial cells, followed by the dysplasia-carcinoma 
sequence.2 Papillomatosis of the bile duct can cause bile 
duct obstruction and dilatation. Patients usually present with 
abdominal pain, jaundice, and acute cholangitis. Mechani-
cal obstruction due to enlarging papilloma can cause septic 
cholangitis and hepatic failure.
Biliary papillomatosis is likely probably misdiagnosed of-
ten as biliary stones and typically remains unrecognized for 
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Fig. 1. (A) Two-dimensional thick-sec-
tion rapid acquisition with relaxation 
enhancementimage shows an irre-
gular intraluminal filling defect in the 
common bile duct and left intra-
hepatic duct (arrows). Both intrahe-
patic ducts are dilated. (B) Papillary 
atypical epithelial proliferation in the
left intrahepatic duct 1st portion 
before photodynamic therapy (H&E 
stain, ×100).
a long time. Thus, patients typically experience aggravated 
papillomatosis before presenting, and have to undergo ex-
tensive liver resection after diagnosis. Naturally, due to wor-
sening prognoses and delayed diagnosis, resection may not 
be possible.
The mean survival period following resection was 28 
months; patients without resection had a survival period of 
less than 11 months.2 Surgical resection has been consid-
ered the only therapeutic option for biliary papillomatosis 
patients. However, it can often remain incomplete because 
of high risk of recurrence or multifocality. Liver transplanta-
tion is also regarded as curative treatment.3 Patients could 
undergo percutaneous transhepatic biliary drainage (PTBD) 
to relieve their symptoms before surgery. Biliary papilloma-
tosis is a disease of advanced age in the sixth-to-seventh dec-
ade of life and is twice as common in males as females.4 
Preoperative evaluation includes CT scan, MRI, and/or ERCP.
CASE REPORT
A healthy 56-year-old man was diagnosed with common 
bile duct (CBD) stenosis by MRI during a routine checkup in 
December 2011. ERCP revealed a suspicious papillomatosis 
involving the common hepatic duct (CHD), both proximal in-
trahepatic bile ducts (IHD), and the right posterior IHD. Papil-
lary dysplasia of CHD was confirmed by the biopsy. Tumor 
marker (CEA, 1.3 U/mL; CA 19-9, 8.0 U/mL) was normal. 
Serum AST/ALT was 28/25, and the cholestatic enzymes 
(ALP, 276 IU/L; GGT, 103 IU/L) were mildly elevated. After bili-
ary decompression by endoscopic nasobiliary drainage, the 
patient was transferred to our institution for surgery (Fig. 1).
Before surgery, PTBD was performed at S3 IHD, and biliary 
ductal dilatation was performed twice by 12 Fr and 18 Fr cath-
eter at a two-day interval. Intraductal papillomatory change 
from distal CBD to right posterior IHD and left IHD 2nd portion 
was found on percutaneous transhepatic cholangioscopy 
(PTCS) (Fig. 2). Two weeks later, photodynamic therapy (PDT) 
was performed to avoid extensive liver resection and recur-
rence. First, PDT was performed from the point of the hilum 
to mid-CBD and the left and right IHD with 180 J for 450 sec-
onds, three times during one day. One day later, a second 
round of PDT was performed only from the hilum to the left 
IHD twice at the same dosage. The patient presented with 
acute cholangitis with fever and bilirubin elevation (highest 
total bilirubin 7.2) after procedures. Symptoms disappeared, 
and bilirubin was down by administration of intravenous 
antibiotics.
There was no evidence of obstruction, severe stricture, or 
remnant papillomatosis of the CBD and both IHD on PTCS one 
month after the second round of PDT, and all of the previously 
detected papillomatosis lesions were improved. After portal 
vein embolization, the patient underwent extended right 
hemihepatectomy in June 2012. There was no intraperi-
toneal metastasis, and complete resection was performed 
(Fig. 2). Pathologic results showed total necrotic change of 
IHD with chronic cholangitis, hepatolithiasis, and foreign 
body reaction was observed, and there was no lymphatic 
metastasis. 
After postoperative 13 months, PTCS was followed and 
granulomatous tissue and IHD stones were found on the left 
main duct. The biopsy result showed local recurrence with 
papillary atypical epithelial proliferation from anastomosis 
site to left IHD. After postoperative 13 months, chemo-
radiation therapy with tegafur-uracil and 45 Gy was ad-
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Fig. 2. (A, B) Percutaneous transhe-
patic cholangioscopy before photo-
dynamic therapy (PDT) shows diffuse
biliary papillomatosis from the distal
common bile duct to the left intrahe-
patic duct 2nd portion. (C) Damaged 
epithelial cells and scars after PDT, 
and there is no evidence of remnant
papillomatosis. (D) Pathologic speci-
men from right extended hepatec-
tomy.
ministered due to local recurrence. There were no local recur-
rences or distant metastases afterwards. 
DISCUSSION
This study is the first case report on PDT with volume re-
serving surgery in Korea. The patient was still alive over 30 
months despite local recurrence. Biliary papillomatosis had 
been regarded as benign or low malignant potential, but a re-
cent review reported a high rate of malignant occurrence 
(41%),2,5,6 and a single center in Korea reported malignant 
occurrence in 83% of 58 patients.7 Resection is usually rec-
ommended for treatment of biliary papillomatosis, and re-
sectability depends on the location and extent of disease be-
cause of the malignancy, high recurrence rates, and multi-
focality.
PDT was established for treatment of Barrett’s esophagus, 
lung cancer, and bile duct cancer8 and was first reported in 
1991 by McCaughan et al.9 for treatment of extrahepatic bile 
duct cancer. It may be a suitable therapeutic choice for pa-
tients with recurrent biliary papillomatosis after resection or 
who are not eligible for surgery. PDT has been used by means 
of intravenous administration of hematoporphyrin derivative 
and followed by laser exposure with proper wavelength. After 
local application, a photosensitizing agent concentrates in 
the lesion. 
In general, the argon dye laser has been used with con-
tinuous wave and penetrates with the thermal change in the 
biliary papillomatosis lesion.10 The pulsed excimer dye laser 
penetrates into deeper layers and activates the photosen-
sitizer more effectively without thermal change.10 The sub-
sequent destruction of neoplastic tissue is a photochemical 
process which contributes to disturbance of the microva-
sculature and degradation of membrane by oxygen radicals.8 
PDT was performed using ERCP guidance. Cholangitis is a 
major complication after PDT,10 thus biliary drainage is in-
evitably required for prevention of cholangitis and biliary 
sepsis. 
Diffuse biliary papillomatosis shows a high recurrence 
rate after surgical resection. Thus, radical hepatectomy or liv-
er transplantation is the preferred therapeutic choice for bilo-
bar or recurrent disease. Successful PDT can be ancillary for 
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achievement of R0 resection, avoiding extensive resection or 
re-operation in advanced intrahepatic and extrahepatic 
papillomatosis. It can give good results for the patient in 
terms of better quality of life and prolonged lifespan.
The mean survival period following resection was 28 
months; patients without resection had a survival period of 
less than 11 months.2 Surgical resection has been consid-
ered the only therapeutic option for biliary papillomatosis 
patients. However, surgical resection can often remain in-
complete, with a high risk of recurrence or multifocality. Thus, 
liver transplantation is also considered to be curative treat-
ment.3 In this case, the patient had PDT, and extensive surgi-
cal resection was avoided.
Some patients could not be treated surgically because of 
their comorbidities, such as cardiopulmonary disease, and 
the extent of the carcinoma. PDT could have been used as a 
local cancer therapy, especially for elderly patients. Suzuki et 
al.10 reported on the efficacy of PDT for bile duct carcinoma 
in four elderly patients for whom surgery was not possible. 
Three of four patients survived over 20 months without surgi-
cal resection, showing improvement in survival compared 
with 11 months survival without resection. In another case 
report of a successful PDT for biliary papillomatosis in the dis-
tal CBD in Turkey, the patient survived for 10 years.8 This pa-
tient underwent the Whipple procedure in 1996 and a 2nd 
operation, right hepatectomy and hepaticojejunostomy was 
performed in 2002 because of recurrence. Due to recur-
rence again in 2004 and 2005, photodynamic therapy was 
administered, because repeated operations were no longer 
possible. After three applications of PDT, bile duct epithelium 
showed normal macroscopic and histological appearance. 
He died in 2006 of multi organ failure because of pneumonia 
and decompensated liver cirrhosis. 
Nevertheless, this case also shows that PDT could improve 
the quality of life and prolong life expectation when compared 
with median survival rate. In Korea, only a few biliary papil-
lomatosis cases have been reported. However, most of them 
underwent surgical resection or palliative drainage for ob-
struction. 
In conclusion, biliary papillomatosis has malignant poten-
cy. It is easily misdiagnosed, even in patients with typical 
symptoms or when proper preoperative evaluation has been 
performed. Once diagnosed, surgical resection is considered 
the only therapeutic option for biliary papillomatosis, and the 
survival rate is very low after resection. Furthermore, many 
patients require repeat or extensive surgery because of re-
currence after resection. Therefore, PDT can be considered 
as a beneficial treatment for patients with bilobar or recur-
rent biliary papillomatosis after resection. It can show good 
results in terms of quality of life and prolonged lifespan.
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